SCHEMBL7292887

SCHEMBL7292887

Cc1c(CN2CCc3[nH]c4c(F)cccc4c3C2=O)ncn1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
ADRA2C P18825 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36
HTR2B P41595 1/20 0.36
HTR3A P46098 1/20 0.36
KCNH2 Q12809 1/20 0.36
CASP6 P55212 1/20 0.36
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
SCN9A Q15858 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL752 0.87 CYP1A2 (0.39) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
SCHEMBL7302315 0.78 CYP1A2 (0.56) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Maleic Acid SCHEMBL7292838 0.74 CYP1A2 (0.50) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Fumaric Acid SCHEMBL7292841 0.74 CYP1A2 (0.50) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
SCHEMBL9090387 0.71 KCNH2 (0.39) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
SCHEMBL7377666 0.69 KCNH2 (0.39) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
SCHEMBL851 0.68
SCHEMBL9270613 0.67 DRD2 (0.41)
SCHEMBL9596253 0.67 TP53 (0.35) CYP1A2CYP3A4HTR2CHTR2BHTR3A
SCHEMBL9267273 0.66 DRD2 (0.43) KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0353983-B1 Lactam derivatives GLAXO GROUP LTD (GB) 1996-05-29 EP disclosed
US-5183820-A Useful for treatment of nausea, vomiting, irritable bowel syndrome and dyspepsia GLAXO GROUP LIMITED (GB) 1993-02-02 US disclosed
EP-0353983-A2 Lactam derivatives GLAXO GROUP LIMITED (GB) 1990-02-07 EP disclosed